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In some cases, these cells were treated with the ROS generation
inducer menadione (100 mM) for 1 hour after A-769662 stimulation.
Total cellular DNA was isolated and used for mtDNA damage analysis
by regular PCR for the presence of the mt 4977-bp DNA deletion
(viewed on agarose gels). Cell lysates were prepared and subjected to
Western blot analyses for phosphorylation and expression of AMPKa,
expression of OGG1 and SIRT3. Mitochondria-targeted OGG1 was
overexpressed in chondrocytes via plasmid transfection. The trans-
fected cells were tested for mtDNA damage in response to menadione,
as well as nitric oxide (NO) release after stimulation with IL-1b (10 ng/
ml) for 18 hours.
Results: Human knee OA (grade 4) chondrocytes, compared with nor-
mal chondrocytes, exhibited reduced phosphorylation of AMPKa and
expression of SIRT3 and OGG1, and robust levels of the mt 4977-bp DNA
deletion. In addition, the samemtDNA deletion mutant was observed in
chondrocytes treated with menadione, suggesting ROS-induced mtDNA
damage. However, A-769662 inhibited generation of the mt 4977-bp
DNA deletion in either human knee OA chondrocytes or chondrocytes
treated with menadione, and concurrently increased expression of
SIRT3 and OGG1. Interestingly, overexpression of OGG1 in chondrocytes
not only reduced generation of themtDNA 4977-bp deletion induced by
menadione, but also signiﬁcantly inhibited NO IL-1b-induced NO
release by about 41% (p<0.0001).
Conclusions: Mitochondrial DNA damage in human knee OA chon-
drocytes is associated with decreased AMPK activity. Conversely,
pharmacologic activation of AMPK limits ROS-induced mtDNA damage
and reverses signiﬁcant amount of mtDNA damage pre-existing in the
OA chondrocytes, mediated at least in part by inhibiting oxidative stress
and increasing DNA repair capacity via upregulation of SIRT3 and OGG1.
These ﬁndings identify a novel molecular mechanism of activation of
AMPK on mitochondrial DNA integrity in articular chondrocytes, and
further support the translational potential of targeted activation of
AMPK for OA.
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DYSREGULATED ATP EFFLUX MECHANISMS IN OSTEOARTHRITIC
CHONDROCYTES
A.K. Rosenthal y,z, J. Ninomiya y, C. Gohr y, E. Mitton-Fitzgerald y. yMed.
Coll. of Wisconsin, Milwaukee, WI, USA; z Zablocki VA Med. Ctr.,
Milwaukee, WI, USA
Purpose: Extracellular ATP (eATP) plays a key role in cartilage health
and disease. Low levels of eATP regulate mechanotransduction, while
high levels produce arthritogenic calcium crystals, signal via purinergic
receptors to elicit catabolic cytokines and prostaglandins , contribute to
inﬂammation through innate immune system signaling, and produce
pain. ATP efﬂux is regulated in an osmomechano-sensitive manner
which is reﬂected in vitro by a surge in [eATP] after exposure to
mechanical or osmotic stress. We recently showed that basal eATP
levels in normal adult primary porcine articular chondrocyte cultures
are critically regulated by levels of the gene product of the progressive
ankylosis gene (ANK) , while the transient receptor potential vanilloid 4
(TRPV4) is necessary for increased ATP efﬂux with osmotic stress. We
sought to determine if similar patterns of eATP efﬂux were observed in
primary OA chondrocytes.
Methods: After obtaining informed consent and with local institutional
review board approval, human articular hyaline cartilage was obtained
at the time of knee joint replacement for OA. Normal human chon-
drocytes were obtained from Lonza and grown and differentiated
according to manufacturer’s directions. All cells were plated at 4 x105/
cm2 in short term high density primary cultures. For osmotic challenge,
30 % of the media was removed and replaced with sterile water. Con-
trols were performed by removing 30% of the media and replacing it
with fresh media. After 10 minutes, eATP levels were measured in the
media using a standard bioluminescent assay (Sigma ATP Assay Mix
(FLAAM)). Cultures were exposed to pharmacologic agonists and
antagonists of ATP efﬂux pathways and modulators of calcium ﬂux and
TRPV4 for 30 minutes before basal and osmotically-challenged levels of
eATP were measured.Results: Basal levels of eATP varied considerably in the OA chondrocytes
with average values of 4.76 ± 4 nM/mg protein and 6.8±3 nM/mg
protein in normal chondrocytes . Both cell types responded to osmotic
stress by increasing [eATP], but the magnitude of this increase in OA
chondrocytes was less than that observed with normal chondrocytes
(2.52 ± 1.4 fold in OA ( n¼23) vs 4.52± 2.1 fold increase in normal
chondrocytes (n¼4) (p¼ 0.04). The ANK channel inhibitor, probenecid,
decreased levels of ATP under both basal and osmotically-challenged
conditions in OA and normal chondrocytes ( n¼ 9, p<0.03). No stat-
istically signiﬁcant responses were seen in normal or OA chondrocytes
with exposure to other ATP efﬂux inhibitors including those blocking
pannexin and connexin hemichannels, VARC/VSOAC or maxianion
channels, or vesicular transport. In contrast to normal chondrocytes, OA
chondrocytes demonstrated no increase in [eATP] after exposure to a
calcium ionophore and did not alter their [eATP] after an osmotic
challenge if BAPTA was used to stabilize intracellular calcium levels
(p¼0.5). Responses to the TPRV4 agonist GSK1016790A and antagonist
HC067047 were also blunted in OA compared to normal chondrocytes.
TPV4 western blotting conﬁrmed reduced TRPV4 protein levels on OA
compared to normal chondrocytes.
Conclusions: OA chondrocytes display a blunted response to osmotic
stress which is likely related to low levels of TRPV4. Probenecid, an ANK
inhibitor, potently reduces [eATP] in both normal and OA chondrocytes ,
and ANK remains an important pharmacologic target in cartilage dis-
eases associated with excess eATP elaboration.
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THE REGULATORY ROLE OF THE C-TERMINAL DOMAIN OF CONNEXIN
43 IN ARTICULAR CARTILAGE
R. Gago-Fuentes y,z, J.F. Bechberger x, F.J. Blanco k,¶, C. Naus x,
M.D. Mayan y,z. yCartilage Biology Res. Group, Rheumatology Div., INIBIC-
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Purpose: Gap junction (GJ) channels are composed by a family of
structurally-related transmembrane proteins called connexins. GJs
were ﬁrst discovery in myocardium and nerve because their properties
of electrical transmission between adjacent cells. However nowadays is
well know that connexins play clinical roles in the function of multi-
cellular organisms. The ability to synchronize groups of cells for coor-
dinated electrical, mechanical, metabolic and chemical communication
make these proteins essential for tissue function. Mutations in con-
nexin-encoding genes lead to developmental of a wide variety of dis-
eases. Chondrocytes in adult cartilage and growth plate express
Connexin 43 (Cx43) and gap junction intercellular communication
(GJIC) has been demonstrated to occur in human primary chondrocytes
and cartilage in vitro and in vivo. The inhibition of GJIC in micromass
culture of chondrocytes reduces chondrocytes differentiation and
defective Cx43 functions cause skeletal defects. Recent results from our
group and others have convincingly demonstrated the involvement of
the overexpression of Cx43 in OA pathogenesis. Cx43 has multiple GJ-
independent functions that affect signalling pathways, cell growth, and
cell proliferation. The carboxy terminal domain (CTD) of Cx43 is located
in the cytoplasmic side and is key for protein functions. The aim of this
study was to investigate the role of the CTD of Cx43 in cartilage struc-
ture and function.
Methods: Global knockout of Cx43 is embryonic lethal and homo-
zygous K258stop animals, which Cx43 lacks the last 125 amino acid
residues of the CTD, died shortly after birth. Cartilage and primary
chondrocytes of 8 wild type, Cx43/KO, 6 K258stop/Cx43, 6 K258stop/KO
and 6 K258stop/K258stop (21-day gestational section age mice) were
subjected to the study. Mouse genotyping was achieved by PCR using
DNA extracted from ear tissue and western-blot. The entire knee joints1 www.mayan-lab.com
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before embedding and sectioning) and analysed by conventional
staining methods and immunohistochemistry (IHC) assays. Chon-
drocytes from cartilage were isolated using an inverted microscope and
tissue was digested using trypsin and collagenase. Primary chon-
drocytes were grown to 80-90% conﬂuence. Proliferation assay was
performed by counting cells with using automated cell counter. For IHC
cells were seed onto coverslips. The following are the antibodies used in
this study: anti-osteoponin, anti-ﬁbronectin, anti-collagen type II, anti-
Cx43, anti-PCNA and Ki67. Scrape loading assay was used to examine
GJIC
Results: Analysis of cartilage sections staining with Safranin O/Fast
Green, Hematoxylin-eosin eosin and Toluidine blue did not show sig-
niﬁcant differences between different phenotypes. However the
K258stop/KO cartilagewas thinner thanwild type and Cx43/KO. Besides
cartilage from K258stop/KO showed higher rate of positive cells for
PCNA. IHC experiments revealed that K258stop/KO chondrocytes in
primary culture contain less levels of collagen type II. K258stop/
K258stop was found to have 1.5-fold increase in cell proliferation in
comparison with wild type or Cx43/KO. Scrape loading assays suggest
that the deletion of CTD slightly reduce GJIC.
Conclusions: We have used a genetically modiﬁed murine model to
directly characterize, for the ﬁrst time, the role of the CTD of Cx43 on
cartilage structure. Our results strongly support the notion that the CTD
of Cx43 plays an important role in chondrocyte phenotype. It is well
know that through its CTD, Cx43 serves as scaffolding proteins that
associates with structural and signaling molecules leading to regulation
of intracellular signaling, independently of channel activity. This study
illustrates that a complete isolation of Cx43 from its CTD may have a
negative impact on cartilage structure and chondrocyte functions
within the tissue.
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THE EFFECTS OF THREE DIFFERENT CLASSES OF ANTI-
INFLAMMATORY AGENTS ON IN VITRO HUMAN OSTEOARTHRITIC
CHONDROCYTES EXPOSED TO IL-1b
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Purpose: VA694, a promising cyclooxigenase-2 (COX-2)-inhibiting
hybrid drug endowed with nitric oxide (NO) releasing properties (NO-
COXIB), showed COX-2-selective inhibitory effects, associated with
interesting anti-inﬂammatory and anti-nociceptive activities. For these
reason we performed an in vitro study to explore the effects of VA694
on cartilage metabolism, in comparison with Naproxcinod, a COX
inhibitor and NO donor (CINOD), and naproxen, a traditional non ster-
oidal-anti-inﬂammatory drug (NSAID) on human osteoarthritic chon-
drocyte cultures.
Methods: Human articular cartilage was obtained from femoral
heads of 5 patients (range 63-71 years) with Osteoarthritis (OA)
according to ACR criteria undergoing surgery for total hip pros-
theses. The chondrocytes were isolated from the articular cartilage
using sequential enzymatic digestion. The primary cultures so
obtained were seeded in 6-well plates until conﬂuence. Cells were
then incubated with two concentrations (1mg/ml and 10mg/ml) of
VA694, Naproxcinod and naproxen alone or in combination with
Interleukin (IL)-1b (5ng/ml) for 48h. In these experimental con-
ditions we evaluated cell viability by MMT assay, release of pros-
taglandin (PG)E2 through an ELISA kit, COX-2 and
metalloproteinases (MMP)-3, -9, -13 gene expression by real time
PCR, and activation of nuclear factor (NF)-kb by immunocy-
tochemistry. Data are expressed as the mean ± standard deviation
of triplicate values for each experiment. Statistical analysis wasperformed using an analysis of variance followed by Bonferroni
multiple comparison tests.
Results: VA694, Naproxcinod and naproxen tested alone at two differ-
ent concentrations studied didn’t signiﬁcantly modify cell viability,
while IL-1b-stimulated chondrocytes showed a signiﬁcant decrease in
cell viability (p<0.001). Both concentrations of all drugs tested restored,
in a signiﬁcant manner (p<0.01), cell proliferation.
No signiﬁcant modiﬁcation of PGE2 levels was observed in the
chondrocyte cultures treated with each of these drugs alone. The
presence of IL-1b determined a signiﬁcant increase (p<0.001, p<0.01,
p<0.01 respectively) in PGE2 levels and both concentrations of
VA694, Naproxcinod and naproxen, signiﬁcantly decreased the PGE2
levels in cells damaged with IL-1b (p<0.001, p<0.05, p<0.05
respectively).
We investigated the COX-2, MMP-3, -9, -13 gene expression by real time
PCR. VA694, Naproxcinod and naproxen tested at two different con-
centrations alone not signiﬁcantly modify the gene expression, while
IL-1b-stimulated chondrocytes induced a very signiﬁcant increase in
COX-2, MMP-3, -9, -13 gene expression (p<0.001). All the drugs tested
in our study signiﬁcantly inhibited COX-2 and MMP-3, -9, -13 gene
expression induced by IL-1b at both concentrations analysed (p<0.01,
p<0.05, p<0.05 respectively).
VA694, Naproxcinod and naproxen pre-treatment were able to inhibit
IL-1b-induced NFkB activation, as measured by its nuclear translocation
(p50 and p65 subunits). Naproxcinod and naproxen pre-treatment
didn’t affect cytoplasmic NFkB levels, while VA694 was able to decrease
the cytoplasmic levels of both subunits (Figure 1, Figure 2).
Conclusions: The results of the present study suggest that VA694,
Naproxcinod and naproxen exert anti-inﬂammatory and chon-
droprotective effects. These drugs in fact inhibit the production of PGE2,
COX-2 and MMP-3, -9, -13 gene expression, stimulated by IL-1b.
However, VA694 seems to have a more efﬁcient effect on NF-kB
inhibition.
Fig 1. Localization of NFkB, red (p50), green (p65) subunits by Immuno-
cytochemistry. Scalebar 50mm.
